Let-7a Is a Direct EWS-FLI-1 Target Implicated in Ewing's Sarcoma Development.

Details

Ressource 1Download: BIB_1A7BFEC48168.P001.pdf (1608.91 [Ko])
State: Public
Version: Final published version
Serval ID
serval:BIB_1A7BFEC48168
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Let-7a Is a Direct EWS-FLI-1 Target Implicated in Ewing's Sarcoma Development.
Journal
Plos One
Author(s)
De Vito C., Riggi N., Suvà M.L., Janiszewska M., Horlbeck J., Baumer K., Provero P., Stamenkovic I.
ISSN
1932-6203 (Electronic)
ISSN-L
1932-6203
Publication state
Published
Issued date
08/2011
Volume
6
Number
8
Pages
e23592
Language
english
Abstract
Ewing's sarcoma family tumors (ESFT) are the second most common bone malignancy in children and young adults, characterized by unique chromosomal translocations that in 85% of cases lead to expression of the EWS-FLI-1 fusion protein. EWS-FLI-1 functions as an aberrant transcription factor that can both induce and suppress members of its target gene repertoire. We have recently demonstrated that EWS-FLI-1 can alter microRNA (miRNA) expression and that miRNA145 is a direct EWS-FLI-1 target whose suppression is implicated in ESFT development. Here, we use miRNA arrays to compare the global miRNA expression profile of human mesenchymal stem cells (MSC) and ESFT cell lines, and show that ESFT display a distinct miRNA signature that includes induction of the oncogenic miRNA 17-92 cluster and repression of the tumor suppressor let-7 family. We demonstrate that direct repression of let-7a by EWS-FLI-1 participates in the tumorigenic potential of ESFT cells in vivo. The mechanism whereby let-7a expression regulates ESFT growth is shown to be mediated by its target gene HMGA2, as let-7a overexpression and HMGA2 repression both block ESFT cell tumorigenicity. Consistent with these observations, systemic delivery of synthetic let-7a into ESFT-bearing mice restored its expression in tumor cells, decreased HMGA2 expression levels and resulted in ESFT growth inhibition in vivo. Our observations provide evidence that deregulation of let-7a target gene expression participates in ESFT development and identify let-7a as promising new therapeutic target for one of the most aggressive pediatric malignancies.
Pubmed
Web of science
Open Access
Yes
Create date
13/09/2011 10:44
Last modification date
20/08/2019 12:51
Usage data